News | Heart Failure | September 06, 2017

Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level

Survey finds that while clinicians identified most patients as high risk, few patients self-identified as high risk

Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level

September 6, 2017 — Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death, while few of those patients considered themselves to be at high risk, according to a study published recently in JACC: Heart Failure.

Physicians rated 161 patients for perceived risk for transplant, LVAD or death in the upcoming year. The patients were also surveyed about their perceptions of their life expectancy and willingness to undergo different treatment options.

Sixty-nine percent of the patients were considered at high risk for transplant, LVAD or death by their physicians. However, only 14 percent of patients considered themselves to be at high risk. Over 13 months of follow-up, 38 percent of patients experienced an endpoint: 21 percent deaths, 8 percent transplants and 9 percent LVAD implants.

“It was surprising that there were such drastic differences between patient perceptions and physician perceptions of heart failure disease severity,” said Amrut V. Ambardekar, M.D., an assistant professor in the division of cardiology at the University of Colorado and the study’s lead author. “We hope better understanding these differences will facilitate improved patient-physician communication regarding advanced heart failure therapies.”

Researchers also assessed patient willingness to consider other life sustaining therapies to treat advanced heart failure, such as ventilation, dialysis or a feeding tube. Among the patients identified as high-risk by physicians, 77 percent were willing to consider LVAD, but 63 percent indicated they would decline other simpler life-sustaining therapies.

“More than likely, these inconsistencies indicate a poor understanding of these treatment options,” Ambardekar said. “Patients may not fully appreciate the invasive nature of some of these procedures, so we probably need to look for better ways to educate our patients both on the severity of their disease and their treatment options – well before they need these advanced therapies.”

“This work highlights the importance of increasing the educational awareness of our patients and the need for more research in this area,” said Christopher M. O’Connor, M.D., FACC, editor-in-chief of JACC: Heart Failure.

Study limitations include that the categorization of physician and patient risk, as well as the patients’ opinions on treatment options, were made at the time of enrollment. According to the researchers, it is likely that perceptions of risk and the patients’ understanding of treatment options changed over the course of time.

For more information: www.heartfailure.onlinejacc.org

Related Content

HHS Releases Second Edition of Physical Activity Guidelines for Americans
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
Overlay Init